Lipid profiles and persisting inflammation following critical illness in a Central Australian population: A prospective longitudinal observational study

Internal Medicine Journal

Volumn 43, Issue 4, 2013, Pages 445-449

  Secombe, P J ^a   Brown, A ^b   Kruger, P S ^c,d   Stewart, P C H ^a  

^a ALICE SPRINGS HOSPITAL   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cholesterol; Infection; Intensive care; Lipid profile

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE DISEASE; ADULT; ARTICLE; AUSTRALIA; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CRITICAL ILLNESS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; LIPOPROTEIN BLOOD LEVEL; LONGITUDINAL STUDY; MALE; OBSERVATIONAL STUDY; POPULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AUSTRALIA; CRITICAL ILLNESS; FEMALE; HUMANS; INFLAMMATION; LIPOPROTEINS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OCEANIC ANCESTRY GROUP; PROSPECTIVE STUDIES;

EID: 84875684039     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12086     Document Type: Article

References (14)

1. Gordon BR, Parker TS, Levine DM, Saal SD, Wang JC, Sloan BJ etal. Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. Crit Care Med 1996; 24: 584-589.
2. Van Leeuwen HJ, Heezius EC, Dallinga GM, van Strijp JA, Verhoef J, van Kessel KP. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 2003; 31: 1359-1366.
3. Murch O, Collin M, Hinds CJ, Thiemermann C. Lipoproteins in inflammation and sepsis. I. Basic science. Intensive Care Med 2007; 33: 13-24.
4. Barlage S, Gnewuch C, Liebisch G, Wolf Z, Audebert FX, Gluck T etal. Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation. Intensive Care Med 2009; 35: 1877-1885.
5. Chien JY, Jerng JS, Yu CJ, Yang PC. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med 2005; 33: 1688-1693.
6. Wu A, Hinds CJ, Thiemermann C. High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications. Shock 2004; 21: 210-221.
7. Wendel M, Paul R, Heller AR. Lipoproteins in inflammation and sepsis. II. Clinical aspects. Intensive Care Med 2007; 33: 25-35.
8. O'Neal DN, Piers LS, Iser DM, Rowley KG, Jenkins AJ, Best JD etal. Australian Aboriginal people and Torres Strait Islanders have an atherogenic lipid profile that is characterised by low HDL-cholesterol level and small LDL particles. Atherosclerosis 2008; 201: 368-377.
9. Kopple JD. The phenomenon of altered risk factor patterns or reverse epidemiology in persons with advanced chronic kidney failure. Am J Clin Nutr 2005; 81: 1257-1266.
10. Thomson N, Stumpers S. Summary of indigenous health: end-stage renal disease. 2007. Australian Indigenous HealthInfoNet, Edith Cowan Univerisity; [cited 2011 Jan 16]. Available from URL: http://www.healthinfonet.ecu.edu.au/chronic-conditions/kidney/reviews/other-reviews
11. Australian Bureau of Statistics. National Regional Profile, Central NT (Statistical Subdivision). Canberra: Australian Bureau of Statistics; 2010.
12. Gruber M, Christ-Crain M, Stolz D, Keller U, Muller C, Bingisser R etal. Prognostic impact of plasma lipids in patients with lower respiratory tract infections - an observational study. Swiss Med Wkly 2009; 139: 166-172.
13. Royal College of Pathologists of Australasia. The RCPA manual. 2011. [cited 2011 Jan 16]. Available from URL: http://www.rcpamanual.edu.au
14. Kruger PS. Forget glucose: what about lipids in critical illness? Crit Care Resusc 2009; 11: 305-309.